Aristotle Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,992	Closed	-$202K	–	172
2023 Q3	$202K	Sell	17,992 -53	-0.3%	-$615	﹤0.01%	170
2023 Q2	$182K	Sell	18,045 -51	-0.3%	-$473	﹤0.01%	170
2023 Q1	$170K	Sell	18,096 -725	-4%	-$8.55K	﹤0.01%	172
2022 Q4	$230K	Sell	18,821 -5,898,680	-100%	-$73.5M	﹤0.01%	175
2022 Q3	$73.4M	Sell	5,917,501 -23,527,520	-80%	-$411M	0.16%	55
2022 Q2	$578M	Buy	29,445,021 +30,384	+0.1%	+$719K	1.22%	39
2022 Q1	$767M	Buy	29,414,637 +203,795	+0.7%	+$5.43M	1.4%	38
2021 Q4	$829M	Buy	29,210,842 +1,027,512	+4%	+$32M	1.4%	37
2021 Q3	$899M	Buy	28,183,330 +176,853	+0.6%	+$5.93M	1.7%	31
2021 Q2	$972M	Buy	28,006,477 +383,942	+1%	+$12.7M	1.86%	29
2021 Q1	$813M	Buy	27,622,535 +2,421,880	+10%	+$74.5M	1.66%	32
2020 Q4	$773M	Buy	25,200,655 +1,099,886	+5%	+$33.6M	1.92%	26
2020 Q3	$673M	Buy	24,100,769 +91,350	+0.4%	+$2.32M	2.03%	25
2020 Q2	$515M	Buy	24,009,419 +13,116,783	+120%	+$290M	1.73%	30
2020 Q1	$244M	Buy	+10,892,636	New	+$298M	1.03%	37